• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

确定急性 Δ-四氢大麻酚(Δ-THC)引起的驾驶和认知障碍的程度和持续时间:系统评价和荟萃分析。

Determining the magnitude and duration of acute Δ-tetrahydrocannabinol (Δ-THC)-induced driving and cognitive impairment: A systematic and meta-analytic review.

机构信息

The University of Sydney, Lambert Initiative for Cannabinoid Therapeutics, Sydney, New South Wales, Australia; The University of Sydney, Brain and Mind Centre, Sydney, New South Wales, Australia; The University of Sydney, Faculty of Science, School of Psychology, Sydney, New South Wales, Australia.

The University of Sydney, Lambert Initiative for Cannabinoid Therapeutics, Sydney, New South Wales, Australia; The University of Sydney, Brain and Mind Centre, Sydney, New South Wales, Australia; The University of Sydney, Faculty of Science, School of Psychology, Sydney, New South Wales, Australia.

出版信息

Neurosci Biobehav Rev. 2021 Jul;126:175-193. doi: 10.1016/j.neubiorev.2021.01.003. Epub 2021 Jan 23.

DOI:10.1016/j.neubiorev.2021.01.003
PMID:33497784
Abstract

The increasing legal availability of cannabis has important implications for road safety. This systematic review characterised the acute effects of Δ-THC on driving performance and driving-related cognitive skills, with a particular focus on the duration of Δ-THC-induced impairment. Eighty publications and 1534 outcomes were reviewed. Several measures of driving performance and driving-related cognitive skills (e.g. lateral control, tracking, divided attention) demonstrated impairment in meta-analyses of "peak" Δ-THC effects (p's<0.05). Multiple meta-regression analyses further found that regular cannabis users experianced less impairment than 'other' (mostly occasional) cannabis users (p = 0.003) and that the magnitude of oral (n = 243 effect estimates [EE]) and inhaled (n = 481 EEs) Δ-THC-induced impairment depended on various factors (dose, post-treatment time interval, the performance domain (skill) assessed) in other cannabis users (p's<0.05). The latter model predicted that most driving-related cognitive skills would 'recover' (Hedges' g=-0.25) within ∼5-hs (and almost all within ∼7-hs) of inhaling 20 mg of Δ-THC; oral Δ-THC-induced impairment may take longer to subside. These results suggest individuals should wait at least 5 -hs following inhaled cannabis use before performing safety-sensitive tasks.

摘要

大麻合法化的日益普及对道路安全有重要影响。本系统综述描述了 Δ-THC 对驾驶表现和驾驶相关认知技能的急性影响,特别关注 Δ-THC 引起的损伤持续时间。共审查了 80 篇出版物和 1534 项结果。几项驾驶表现和驾驶相关认知技能的测量指标(例如,横向控制、跟踪、注意力分散)在“峰值”Δ-THC 效应的荟萃分析中显示出损伤(p<0.05)。多项元回归分析进一步发现,经常使用大麻的人与“其他”(主要是偶尔使用)大麻使用者相比,损伤较小(p=0.003),口服(n=243 效应估计值[EE])和吸入(n=481 EE)Δ-THC 引起的损伤程度取决于其他大麻使用者的各种因素(剂量、治疗后时间间隔、评估的表现领域(技能))(p<0.05)。后一种模型预测,在吸入 20mg Δ-THC 后约 5 小时内(几乎所有在 7 小时内),大多数驾驶相关认知技能将“恢复”(Hedges' g=-0.25);口服 Δ-THC 引起的损伤可能需要更长时间才能消退。这些结果表明,个体应在吸入大麻后至少等待 5 小时,然后再进行安全敏感任务。

相似文献

1
Determining the magnitude and duration of acute Δ-tetrahydrocannabinol (Δ-THC)-induced driving and cognitive impairment: A systematic and meta-analytic review.确定急性 Δ-四氢大麻酚(Δ-THC)引起的驾驶和认知障碍的程度和持续时间:系统评价和荟萃分析。
Neurosci Biobehav Rev. 2021 Jul;126:175-193. doi: 10.1016/j.neubiorev.2021.01.003. Epub 2021 Jan 23.
2
Mechanisms of cannabis impairment: Implications for modeling driving performance.大麻致损机制:对驾驶表现建模的影响。
Forensic Sci Int. 2021 Nov;328:110902. doi: 10.1016/j.forsciint.2021.110902. Epub 2021 Jul 7.
3
The "Next Day" Effects of Cannabis Use: A Systematic Review.使用大麻的“次日”效应:系统评价。
Cannabis Cannabinoid Res. 2023 Feb;8(1):92-114. doi: 10.1089/can.2022.0185. Epub 2022 Dec 6.
4
Cannabinoids for the treatment of dementia.大麻素治疗痴呆。
Cochrane Database Syst Rev. 2021 Sep 17;9(9):CD012820. doi: 10.1002/14651858.CD012820.pub2.
5
Randomized Laboratory Study of Single-Dose Cannabis, Dronabinol, and Placebo in Patients With Schizophrenia and Cannabis Use Disorder.大麻单剂量、屈大麻酚与安慰剂用于精神分裂症合并大麻使用障碍患者的随机实验室研究
Schizophr Bull. 2025 Mar 14;51(2):479-492. doi: 10.1093/schbul/sbae097.
6
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
7
Cannabis-based medicines for chronic neuropathic pain in adults.用于成人慢性神经性疼痛的大麻类药物。
Cochrane Database Syst Rev. 2018 Mar 7;3(3):CD012182. doi: 10.1002/14651858.CD012182.pub2.
8
A Systematic Review of the Efficacy of Cannabinoid Agonist Replacement Therapy for Cannabis Withdrawal Symptoms.大麻戒断症状的大麻素激动剂替代疗法疗效的系统评价。
CNS Drugs. 2018 Dec;32(12):1113-1129. doi: 10.1007/s40263-018-0577-6.
9
The effects of cannabis and alcohol on driving performance and driver behaviour: a systematic review and meta-analysis.大麻和酒精对驾驶性能及驾驶员行为的影响:一项系统评价与荟萃分析。
Addiction. 2022 Jul;117(7):1843-1856. doi: 10.1111/add.15770. Epub 2022 Jan 26.
10
Are blood and oral fluid Δ-tetrahydrocannabinol (THC) and metabolite concentrations related to impairment? A meta-regression analysis.血液和唾液中 Δ-四氢大麻酚(THC)及其代谢物浓度与损伤相关吗?一项荟萃回归分析。
Neurosci Biobehav Rev. 2022 Mar;134:104433. doi: 10.1016/j.neubiorev.2021.11.004. Epub 2021 Nov 9.

引用本文的文献

1
Case Report: Effect of medicinal cannabis on fitness to drive in a patient with Tourette Syndrome and ADHD.病例报告:药用大麻对一名患有妥瑞氏症和注意力缺陷多动障碍患者驾驶适宜性的影响。
Front Psychiatry. 2025 Aug 18;16:1595649. doi: 10.3389/fpsyt.2025.1595649. eCollection 2025.
2
The effects of orally ingested Delta-9-Tetrahydrocannabinol on drivers' hazard perception and risk-taking behaviours: A within-subjects study of medicinal cannabis users.口服Δ-9-四氢大麻酚对驾驶员危险感知和冒险行为的影响:对药用大麻使用者的一项自身对照研究。
Psychopharmacology (Berl). 2025 Jul 31. doi: 10.1007/s00213-025-06869-w.
3
Understanding the Role of Endocannabinoids in Posttraumatic Stress Disorder.
了解内源性大麻素在创伤后应激障碍中的作用。
Int J Mol Sci. 2025 Jun 9;26(12):5527. doi: 10.3390/ijms26125527.
4
Does acute stress induced via cold water immersion increase blood THC concentrations in regular cannabis users?通过冷水浸泡诱导的急性应激是否会增加经常吸食大麻者血液中的四氢大麻酚浓度?
Psychopharmacology (Berl). 2025 Jun 14. doi: 10.1007/s00213-025-06833-8.
5
Impact of naturalistic cannabis use on lateral control and speed: A driving simulator study.自然使用大麻对横向控制和速度的影响:一项驾驶模拟器研究。
Traffic Inj Prev. 2025 Jun 12:1-10. doi: 10.1080/15389588.2025.2508381.
6
Elucidating the acute effects of medically prescribed oral and vaporised delta-9-tetrahydrocannabinol on cognitive functions important for driving.阐明医学处方的口服和雾化Δ-9-四氢大麻酚对驾驶重要认知功能的急性影响。
Drug Alcohol Rev. 2025 May;44(4):1010-1023. doi: 10.1111/dar.14060. Epub 2025 Apr 29.
7
Special Report from the CDC: Driving under the influence of alcohol, marijuana, or other illicit drugs among drivers aged ≥16 years - National Survey on Drug Use and Health, 2016-2019.美国疾病控制与预防中心特别报告:2016 - 2019年全国药物使用和健康调查——16岁及以上驾驶者在酒精、大麻或其他非法药物影响下驾车情况
J Safety Res. 2024 Dec;91:505-515. doi: 10.1016/j.jsr.2024.09.017. Epub 2024 Nov 14.
8
Medicinal Cannabis and Consumer Vulnerability in Australia: A Nexus of Policy and Market Factors.澳大利亚的药用大麻与消费者脆弱性:政策与市场因素的关联
Health Expect. 2025 Feb;28(1):e70176. doi: 10.1111/hex.70176.
9
The driving-related attitudes, beliefs and behaviours of cannabis users in the Australian Capital Territory following decriminalisation.澳大利亚首都地区大麻合法化后大麻使用者与驾驶相关的态度、信念和行为。
Drug Alcohol Rev. 2025 Feb;44(2):588-601. doi: 10.1111/dar.13983. Epub 2025 Jan 7.
10
Research and Clinical Practice Involving the Use of Products, with Emphasis on Cannabidiol: A Narrative Review.涉及产品使用的研究与临床实践,重点是大麻二酚:一项叙述性综述。
Pharmaceuticals (Basel). 2024 Dec 6;17(12):1644. doi: 10.3390/ph17121644.